Alaunos Therapeutics Inc. (TCRT)
NASDAQ: TCRT
· Real-Time Price · USD
2.27
-0.13 (-5.42%)
At close: Aug 15, 2025, 3:59 PM
Alaunos Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 38.52M | 37.91M | 30.81M | -19.13M | -26.77M | -35.14M | -36.46M | -36.83M | -37.99M | -37.73M | -40.37M | -54.25M | -66.98M | -78.75M | -89.73M | -87.31M | -83.24M |
Depreciation & Amortization | -1.35M | -1.35M | -1.1M | 923K | 1.62M | 2.31M | 2.77M | 2.78M | 2.77M | 2.76M | 2.77M | 2.75M | 2.75M | 2.6M | 2.31M | 1.96M | 1.53M |
Stock-Based Compensation | -7.05M | -6.95M | -6.78M | 1.25M | 2.06M | 2.8M | 3.43M | 3.51M | 3.58M | 3.53M | 3.57M | 5.13M | 9.43M | 10.77M | 11.29M | 10.71M | 7.09M |
Other Working Capital | -7.62M | -8.01M | -10.06M | -3.37M | -4.46M | -5.48M | -2.81M | -2.93M | -4.6M | -2.14M | -12.04M | -1.91M | -849K | -1.04M | 5.94M | -2.94M | 1.17M |
Other Non-Cash Items | -729K | -534K | 3.35M | 4.68M | 6.14M | 6.53M | 2.89M | 2.85M | 3.66M | 3.27M | 3.04M | 2.85M | 12.48M | 13.25M | 81.98M | 81.83M | 69.94M |
Deferred Income Tax | n/a | n/a | -1.41M | -401K | -391K | -391K | 1.02M | 10K | n/a | n/a | 740K | 740K | 740K | 740K | -68.97M | -68.97M | -68.97M |
Change in Working Capital | -5.8M | -6.21M | -9M | -4.49M | -5.14M | -6.25M | -3.54M | -1.97M | -2.86M | -1.06M | -6.98M | 2.11M | -437K | 2.79M | 12.6M | 4.77M | 12.21M |
Operating Cash Flow | 23.61M | 22.46M | 15.67M | -17.36M | -22.68M | -30.14M | -29.89M | -29.66M | -30.84M | -29.23M | -37.23M | -40.66M | -53.92M | -61.47M | -63.38M | -69.87M | -62.42M |
Capital Expenditures | n/a | n/a | 2.25M | -1K | -136K | -197K | -313K | -326K | -248K | -216K | -459K | -815K | -2.63M | -3.32M | -6.73M | -8.37M | -9.98M |
Cash Acquisitions | n/a | n/a | 1.5M | 1.5M | 1.5M | 1.54M | 63K | 61K | 61K | 23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 1.54M | 1.54M | 1.54M | 1.58M | 61K | 61K | 61K | 23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | 3.75M | 1.5M | 1.37M | 1.35M | -250K | -265K | -187K | -193K | -459K | -815K | -2.63M | -3.32M | -6.73M | -8.37M | -9.98M |
Debt Repayment | n/a | n/a | 125K | 125K | -11.73M | -17.98M | -24.36M | -26.44M | -14.58M | -8.33M | -2.08M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -45K | -45K | -45K | -45K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -43.05M | -18.11M | -18.23M | -18.23M | -125K | -104K | 21K | 21K | -165K | 24.74M | 24.76M | 25.78M | 26.36M | 1.46M | 1.46M |
Financial Cash Flow | -24.95M | -24.95M | -24.95M | n/a | -11.98M | -18.14M | -9.66M | -11.77M | 209K | 6.37M | -2.29M | 24.74M | 24.76M | 25.78M | 26.36M | 1.46M | 1.46M |
Net Cash Flow | -3.83M | -4.97M | -10.26M | -15.85M | -33.29M | -46.93M | -39.8M | -41.69M | -30.82M | -23.06M | -39.98M | -16.73M | -31.8M | -39.02M | -43.75M | -76.78M | -70.95M |
Free Cash Flow | 25.85M | 24.71M | 17.91M | -17.36M | -22.81M | -30.34M | -30.2M | -29.98M | -31.09M | -29.45M | -37.69M | -41.48M | -56.56M | -64.79M | -70.11M | -78.24M | -72.4M |